Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
stock-price-movement: Archive
J.Jill (JILL) Soars 11.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
J.Jill (JILL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
JILLNegative Net Change TLYSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Costamare (CMRE) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Costamare (CMRE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
CMREPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Aptiv (APTV) Rating Upgrade to Strong Buy
by Zacks Equity Research
Aptiv (APTV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
APTVPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Passage Bio (PASG) Rating Upgrade to Buy
by Zacks Equity Research
Passage Bio (PASG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PASGPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Hanover Insurance (THG) Upgraded to Buy: Here's Why
by Zacks Equity Research
Hanover Insurance (THG) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
THGPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Camtek (CAMT) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Camtek (CAMT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
CAMTNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
What Makes ResMed (RMD) a New Strong Buy Stock
by Zacks Equity Research
ResMed (RMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
RMDNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
StoneCo (STNE) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
StoneCo (STNE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
STNENegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Carrols Restaurant (TAST) Rating Upgrade to Buy
by Zacks Equity Research
Carrols Restaurant (TAST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TASTNo Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Milestone Pharmaceuticals (MIST) Upgraded to Buy: Here's What You Should Know
by Zacks Equity Research
Milestone Pharmaceuticals (MIST) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
MISTPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Palmer Square Capital BDC Inc. (PSBD) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Palmer Square Capital BDC Inc. (PSBD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PSBDPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Dell Technologies (DELL) Surges 11.2%: Is This an Indication of Further Gains?
by Zacks Equity Research
Dell Technologies (DELL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
DELLNegative Net Change AINegative Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Great Southern Bancorp (GSBC)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
GSBCNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Datadog (DDOG) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Datadog (DDOG), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
DDOGPositive Net Change
momentum-investor momentum-stocks stock-price-change stock-price-movement
Maplebear (CART) Loses -9.63% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Maplebear (CART) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
CARTPositive Net Change
rsi stock-price-movement
After Plunging -13.71% in 4 Weeks, Here's Why the Trend Might Reverse for Aligos Therapeutics (ALGS)
by Zacks Equity Research
Aligos Therapeutics (ALGS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
ALGSNegative Net Change
rsi stock-price-movement
After Plunging -12.92% in 4 Weeks, Here's Why the Trend Might Reverse for Hyzon Motors (HYZN)
by Zacks Equity Research
Hyzon Motors (HYZN) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
HYZNPositive Net Change
rsi stock-price-movement
After Plunging -7.64% in 4 Weeks, Here's Why the Trend Might Reverse for Marinus Pharmaceuticals (MRNS)
by Zacks Equity Research
Marinus Pharmaceuticals (MRNS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
MRNSNegative Net Change
rsi stock-price-movement
Down -5.63% in 4 Weeks, Here's Why Kronos Bio (KRON) Looks Ripe for a Turnaround
by Zacks Equity Research
Kronos Bio (KRON) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
KRONPositive Net Change
rsi stock-price-movement
The AZEK Company (AZEK) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Is it a good or bad thing when a stock surpasses resistance at the 50-day simple moving average?
AZEKNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Here's Why Momentum in Northrim (NRIM) Should Keep going
by Zacks Equity Research
Northrim (NRIM) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
NRIMNegative Net Change
price-performance stock-price-change stock-price-movement
Dycom Industries (DY) is on the Move, Here's Why the Trend Could be Sustainable
by Zacks Equity Research
Dycom Industries (DY) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
DYNegative Net Change
price-performance stock-price-change stock-price-movement
All You Need to Know About CI Financial (CIXXF) Rating Upgrade to Strong Buy
by Zacks Equity Research
CI Financial (CIXXF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
CIXXFNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Intapp (INTA) Upgraded to Buy: Here's Why
by Zacks Equity Research
Intapp (INTA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
INTANegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Janus Henderson Group (JHG) Upgraded to Strong Buy: Here's Why
by Zacks Equity Research
Janus Henderson Group (JHG) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
JHGNegative Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank